Professor James is Professor of Clinical Oncology at the University of Birmingham, and Consultant in Clinical Oncology at the Queen Elizabeth Hospital Birmingham. He qualified in 1983 from St Bartholomew’s with the principal class medical prize and undertook postgraduate training in London, Brussels and Tokyo.
He co-founded the leading patient website CancerHelp UK. His clinical practice and research are focussed on urological (prostate, bladder and kidney) cancer. His uro-oncology research spans phase I gene therapy trials to major phase III studies including the STAMPEDE trial, now the largest interventional study in prostate cancer with over 3000 patients recruited to date and featuring a novel multi-arm, multi stage design. Initial results have recently been published in Lancet Oncology.
He has lead a series of trials of chemoradiotherapy in bladder cancer culminating in the BC2001 trial, the largest randomised trial in the field, recently published in the New England Journal of Medicine with an accompanying editorial. He is R&D Director with responsibility for cancer research at the Queen Elizabeth Hospital Birmingham.
This lecture is open to all, pre-registration is not required.
Cost: Free of charge